ERYTECH annuncia l’abstract con i risultati dello studio di fase 2 su eryaspase per la leucemia linfoblastica acuta, selezionato per la presentazione orale al convegno annuale dell’American Society of Hematology 2020

Paul Theisen
Patient Acquisition

Daniel Sontupe
Market Access

Suma Ramadas, PhD
Medical Affairs

Matt Turner
Patient Affordability

Liz Kane
Impactful Strategy

Frank Burrell
Scientific Storytelling

David Linetsky
Point-of-Care Marketing

Amy Giles
Increasing Engagement

Brenda Snow
Authentic Patient Voice

Joey Cohen
Medication Adherence

Stacey Gandler
Brand Nourishment

Matthew Durham
Omnidynamic Marketing

Pat Purcell
Meeting Engagement

Bud Bilanich
Success Coach